A clinical-stage biotechnology company developing therapies for retinal diseases such as wet age-related macular degeneration and diabetic retinopathy. Its pipeline centers on antibody-based drug candidates designed to provide longer-lasting treatment for chronic eye conditions, with lead programs a...
3 members of Congress have disclosed 7 trades in Kodiak Sciences Inc. (KOD), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-11-08 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-07-18 | Christopher L. Jacobs | buy | $1K – $15K |
| 2016-11-23 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2016-11-22 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2016-11-21 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2016-11-18 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2016-09-13 | Kurt Schrader | sell | $1K – $15K |